Booming Homology Inks Deal for Huge New Massachusetts HQ
Things are looking up for Massachusetts-based Homology Medicines. Source: BioSpace
Things are looking up for Massachusetts-based Homology Medicines. Source: BioSpace
CARMA Therapeutics is based on technology from the Center for Cellular Immunotherapies at the University of Pennsylvania, and was spun out of the laboratory of Saar Gill, assistant professor of…
The agency would have to furlough about 45 percent of its staff. Source: BioSpace
Investors and analysts have given it some thought and mostly think it's a sensible acquisition. Source: BioSpace
These stocks have been given a Strong Buy or Buy rating by 80% or more brokers. Source: BioSpace
resTORbio is developing novel therapies to improve immune function in the elderly. Source: BioSpace
On Jan. 8, Alder BioPharma announced that its eptinezumab met its primary endpoint in its Phase III PROMISE 2 clinical trial for preventing migraine. Source: BioSpace
Strongbridge will fund 70% of the costs of a worldwide pediatric development program to be run by Aeterna Zentaris with customary oversight from a joint steering committee. Source: BioSpace
There are many unusual things about Shepherd Therapeutics, but one of them is its origin. Source: BioSpace
Kymriah became the first CAR-T cell therapy to receive regulatory approval when it was approved by the FDA in August 2017. Source: BioSpace